The Neoadjuvant Combined Hormone Therapy in Premenopausal Women With Locally Advanced ER+/HER2- Breast Cancer
Condition: The Neoadjuvant Therapy Interventions: Drug: Ribocyclib, fulvestrant, triptorelin; Drug: Doxorubicin, cyclophosphamide, paclitaxel Sponsor: Saint Petersburg State Budgetary Healthcare Institution, City Clinical Oncology Dispensary Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Breast Cancer | Cancer | Cancer & Oncology | HER2 | Hormonal Therapy | Hormones | Neoadjuvant Therapy | Research | Women